Power Law company profile

Foghorn Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2016 · IPO 2020 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$161M

Market cap · Apr/2026

Revenue

$31M

Latest reported FY

Investors

1 investor on Foghorn Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 1 investor entered at this stage

Global footprint

Web traffic by country

5.7K monthly visits
across markets

🇺🇸 United States77.2%

🇮🇳 India14%

🇯🇵 Japan5.3%

🇨🇦 Canada3.5%

Top 4 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo